Research Study

A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study)
Principal Investigator 
Krishnan Ramanathan

Overview

Body Locations and Systems 
Diabetes - Type 2
Disorders and Conditions 
Diabetes Type 2
Health Conditions 
ClinicalTrials.gov# 
NCT01991795
Status 
Closed to Recruitment
Study Start/End 
Apr 24, 2014 to Mar 30, 2018
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Ngaire Meadows, Research Coordinator
Phone 
604-875-5775
Email Address 
ngaire.meadows2@vch.ca
Purpose of Study 

The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.